Table 1.
Key questions in the field of Acute Stress Reaction (ASR) management
| Question |
|---|
| What is the full range of ASR symptoms? |
| What are the most common ASR symptoms? What is the prevalence of ASR symptoms? |
| Do ASR symptoms co-vary? |
| What are the most common ASR phenotypes? |
| What is the relationship between ASR symptoms/ phenotypes and chronic symptom development? |
| What is the relationship between ASR symptoms/ phenotypes and the risk of ASD/ PTSD onset? |
| What are the neurophysiological underpinnings of ASR symptoms? Do they differ for active versus passive symptoms? Are different medications needed to address active versus passive symptoms? |
| What are the predictors of ASR symptoms? |
| Do men and women differ in their ASR symptom presentations? Do the neurophysiological underpinnings of ASR symptoms differ between men and women? |
| How do we effectively assess the severity of ASRs? Is there a threshold for medication administration? Can we use the same standards to monitor medication efficacy or lack thereof? |
| If an ASR occurs in parallel with trauma, is intervention beneficial or detrimental for long-term responses? |
| If ASR symptoms re-occur will additional dosing with initial medication attenuate symptoms? What symptoms may be treatment resistant? |